Long-term costeffectiveness of Oncotype DX versus current clinical practice from a Dutch cost perspective

Overview of attention for article published in Journal of Comparative Effectiveness Research, April 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (75th percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 1,276 followers.

RT @uhesllc: Long-term cost-effectiveness of Oncotype DX(®) versus current clinical practice from a Dutch cost perspective.... https://t.co…

Long-term cost-effectiveness of Oncotype DX(®) versus current clinical practice from a Dutch cost perspective.... https://t.co/OtHTD2g4TB

RT @fsgcer: Long-term cost–effectiveness of Oncotype DX® vs current clinical practice from a Dutch cost perspective https://t.co/wfJXxg7koH…

RT @fsgcer: Long-term cost–effectiveness of Oncotype DX® vs current clinical practice from a Dutch cost perspective https://t.co/wfJXxg7koH…

Long-term cost–effectiveness of Oncotype DX® vs current clinical practice from a Dutch cost perspective https://t.co/wfJXxg7koH @fredhutch